Titan Pharma: FDA Panel Live Blog Titan Pharma FDA Panel
Titan Pharma: FDA Panel Live Blog
Titan Pharma FDA Panel Live Blog BETHESDA, Md. (TheStreet) -- An FDA advisory panel will spend Thursday reviewing a long-acting treatment for opioid addiction from Titan Pharmaceuticals . The panel is expected to be contentious because FDA 's own reviewers expressed doubts about the ability of Titan's drug, known as Probuphine, to adequately curb addiction. The FDA 's concerns, made public in a ...
Quidel and Life Technologies Receive FDA Clearance for Clostridium difficile Assay and QuantStudio Dx and 7500 Fast ...
SAN DIEGO and CARLSBAD, Calif., March 18, 2013 /PRNewswire/ -- Quidel Corporation (NASDAQ: QDEL) and Life Technologies Corporation (NASDAQ: LIFE) announced today that they received 510(k) clearances from ...
Quidel and Life Technologies Receive FDA Clearance for Clostridium difficile Assay and Quantstudio(TM) DX and 7500 ...
Quidel Corporation and Life Technologies Corporation announced today that they received 510 clearances from the United States Food and Drug Administration to market the Quidel Molecular Direct C. difficile ...